Christopher P Austin Selected Research

Rare Diseases (Rare Disease)

1/2020	Therapies for rare diseases: therapeutic modalities, progress and challenges ahead.
1/2020	Publisher Correction: Therapies for rare diseases: therapeutic modalities, progress and challenges ahead.
1/2019	International collaborative actions and transparency to understand, diagnose, and develop therapies for rare diseases.
12/2017	The International Rare Diseases Research Consortium: Policies and Guidelines to maximize impact.
1/2017	'IRDiRC Recognized Resources': a new mechanism to support scientists to conduct efficient, high-quality research for rare diseases.
1/2017	A Global Approach to Rare Diseases Research and Orphan Products Development: The International Rare Diseases Research Consortium (IRDiRC).
1/2017	Improved Diagnosis and Care for Rare Diseases through Implementation of Precision Public Health Framework.
12/2016	Fostering collaborative research for rare genetic disease: the example of niemann-pick type C disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Christopher P Austin Research Topics

Disease

17	Neoplasms (Cancer) 08/2018 - 04/2008
8	Rare Diseases (Rare Disease) 01/2020 - 12/2016
5	Alzheimer Disease (Alzheimer's Disease) 09/2013 - 02/2002
5	Gaucher Disease (Gaucher's Disease) 01/2012 - 08/2007
4	Type C Niemann-Pick Disease (Niemann Pick Disease, Type C) 08/2017 - 10/2012
4	Schistosomiasis (Bilharziasis) 10/2009 - 01/2008
3	COVID-19 07/2021 - 07/2020
3	Infections 07/2015 - 05/2010
3	Neurodegenerative Diseases (Neurodegenerative Disease) 09/2014 - 01/2012
3	Myotonic Dystrophy (Dystrophia Myotonica) 06/2014 - 02/2012
3	Malaria 01/2013 - 10/2009
3	Inflammation (Inflammations) 05/2010 - 10/2003
3	Hypoxia (Hypoxemia) 12/2009 - 09/2009
2	Disease Progression 01/2021 - 01/2021
2	Adrenocortical Carcinoma 08/2018 - 09/2012
2	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 02/2014 - 02/2007
2	Neglected Diseases 01/2014 - 01/2008
2	Tauopathies 09/2013 - 08/2009
2	Chordoma 07/2013 - 01/2013
2	Lysosomal Storage Diseases (Lysosomal Storage Disease) 11/2012 - 05/2010
2	Cardiovascular Diseases (Cardiovascular Disease) 04/2012 - 08/2008
2	Long QT Syndrome 05/2011 - 11/2009
2	Glycogen Storage Disease Type II (Pompe's Disease) 05/2010 - 07/2009
2	Pain (Aches) 10/2003 - 07/2003
1	Communicable Diseases (Infectious Diseases) 07/2021
1	Severe Acute Respiratory Syndrome 01/2021
1	Breast Neoplasms (Breast Cancer) 01/2019
1	Hepatocellular Carcinoma (Hepatoma) 10/2017
1	Mastoiditis 10/2017
1	Virus Diseases (Viral Diseases) 07/2015
1	Rheumatoid Arthritis 05/2014
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 05/2014
1	Polyostotic Fibrous Dysplasia (McCune Albright Syndrome) 01/2014
1	Fibrous Dysplasia of Bone 01/2014
1	Neuroblastoma 09/2013
1	2 Neuronal Ceroid Lipofuscinosis 11/2012
1	Type A Niemann-Pick Disease 11/2012
1	Wolman Disease (Wolman's Disease) 11/2012
1	Mucopolysaccharidosis III (Sanfilippo Syndrome) 11/2012
1	Carcinogenesis 10/2012

Drug/Important Bio-Agent (IBA)

21	Pharmaceutical PreparationsIBA 07/2020 - 01/2008
16	Proteins (Proteins, Gene)FDA Link 01/2020 - 07/2003
7	EnzymesIBA 01/2012 - 01/2008
5	Glucosylceramidase (Glucocerebrosidase)IBA 01/2012 - 08/2007
4	CholesterolIBA 08/2017 - 10/2012
4	Transcription Factors (Transcription Factor)IBA 09/2012 - 11/2009
3	Pyruvate KinaseIBA 10/2012 - 02/2010
3	Protein Isoforms (Isoforms)IBA 10/2012 - 02/2010
2	AntigensIBA 01/2021 - 01/2021
2	Biomarkers (Surrogate Marker)IBA 01/2019 - 08/2018
2	CyclodextrinsIBA 08/2017 - 10/2012
2	RNA (Ribonucleic Acid)IBA 06/2014 - 02/2012
2	tau Proteins (tau Protein)IBA 09/2013 - 08/2009
2	Digoxin (Digitek)FDA LinkGeneric 07/2013 - 08/2009
2	Adenosine Triphosphate (ATP)IBA 01/2013 - 06/2009
2	Lysergic Acid Diethylamide (LSD)IBA 02/2011 - 05/2010
2	CytokinesIBA 01/2011 - 09/2009
2	alpha-Glucosidases (Acid Maltase)IBA 05/2010 - 07/2009
2	Oxygen (Dioxygen)IBA 12/2009 - 11/2009
2	Peptides (Polypeptides)IBA 08/2009 - 08/2002
2	Fluorescent Dyes (Fluorescent Probes)IBA 08/2009 - 07/2009
2	thioredoxin glutathione reductaseIBA 08/2008 - 01/2008
1	Antiviral Agents (Antivirals)IBA 07/2021
1	OligonucleotidesIBA 01/2020
1	Monoclonal AntibodiesIBA 01/2020
1	alvocidib (flavopiridol)IBA 08/2018
1	CaspasesIBA 08/2018
1	carfilzomibIBA 08/2018
1	dimemorfan (AT 17)IBA 10/2017
1	Indicators and Reagents (Reagents)IBA 01/2017
1	Small Interfering RNA (siRNA)IBA 07/2015
1	Interferon Type IIBA 07/2015
1	Auranofin (Ridaura)FDA Link 05/2014
1	CELF1 ProteinIBA 03/2014
1	ibrutinibIBA 02/2014
1	Drug CombinationsIBA 02/2014
1	GTP-Binding Proteins (G-Protein)IBA 01/2014
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 09/2013
1	Trimetrexate (JB11)FDA Link 07/2013
1	Cantharidin (Cantharides)IBA 07/2013
1	StaurosporineIBA 07/2013
1	Bortezomib (Velcade)FDA Link 07/2013
1	rubitecanIBA 07/2013
1	Investigational DrugsIBA 07/2013
1	Digitoxin FDA Link 07/2013
1	tanespimycin (17AAG)IBA 07/2013
1	VaccinesIBA 01/2013
1	Ketotifen (Ketotifene)FDA Link 01/2013
1	InsecticidesIBA 01/2013
1	ATP-Binding Cassette Transporters (ABC Transporters)IBA 01/2013
1	Sterol Esterase (Hormone-Sensitive Lipase)IBA 11/2012
1	lysosomal proteinsIBA 11/2012
1	LipidsIBA 11/2012
1	Tocopherols (Tocopherol)IBA 11/2012
1	Glucose (Dextrose)FDA LinkGeneric 10/2012
1	Antineoplastic Agents (Antineoplastics)IBA 09/2012

Therapy/Procedure

18	Therapeutics 07/2021 - 08/2007
2	Extracorporeal Membrane Oxygenation 01/2021 - 01/2021
1	Radiotherapy 07/2013
1	Drug Therapy (Chemotherapy) 01/2013